MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CHRS has $516,519K in assets. $428,745K in debts. $103,352K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
123.81%
Quick Ratio
123.26%
Cash Ratio
27.76%
Debt to Asset Ratio
83.01%
Assets Breakdown
    • Tsa receivables, net
    • Cash and cash equivalents
    • Investments in marketable securi...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Tsa payables and accrued liabili...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
103,352 216,893
Investments in marketable securities
88,311 20,744
Trade receivables, net
9,245 5,109
Tsa receivables, net
241,251 114,530
Inventory
2,048 4,513
Prepaid manufacturing
8,048 6,700
Other prepaids and current assets
8,700 11,716
Total current assets
460,955 380,205
Property and equipment, net
1,633 1,907
Intangible assets, net
49,484 52,312
Other assets, non-current
4,447 5,040
Total assets
516,519 439,464
Accounts payable
24,893 37,622
Accrued rebates, fees and reserves
67,010 96,814
Tsa payables and accrued liabilities
253,908 103,999
Accrued compensation
13,385 11,015
Accrued and other current liabilities
13,101 14,179
Total current liabilities
372,297 263,629
Term loan, non-current
36,957 36,867
Lease liabilities, non-current
1,946 2,406
Other liabilities, non-current
17,545 16,735
Total liabilities
428,745 319,637
Common stock (0.0001 par value shares authorized 300,000,000 shares issued and outstanding 116,236,018 and 115,614,548 at september 30, 2025 and december 31, 2024, respectively)
12 12
Additional paid-in capital
1,433,291 1,429,885
Accumulated other comprehensive loss
-203 -275
Accumulated deficit
-1,345,326 -1,309,795
Total stockholders' equity (deficit)
87,774 119,827
Total liabilities and stockholders' equity (deficit)
516,519 439,464
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Other prepaids andcurrent assets$8,700K Prepaid manufacturing$8,048K Inventory$2,048K Tsa receivables,net$241,251K Trade receivables,net$9,245K Investments in marketablesecurities$88,311K Cash and cashequivalents$103,352K Other assets,non-current$4,447K Intangible assets, net$49,484K Property and equipment,net$1,633K Total current assets$460,955K Total assets$516,519K Total liabilities andstockholders' equity...$516,519K Total stockholders'equity (deficit)$87,774K Total liabilities$428,745K Accumulated deficit-$1,345,326K Accumulated othercomprehensive loss-$203K Additional paid-in capital$1,433,291K Other liabilities,non-current$17,545K Lease liabilities,non-current$1,946K Term loan,non-current$36,957K Total currentliabilities$372,297K Common stock (0.0001par value shares...$12K Accrued and othercurrent liabilities$13,101K Accrued compensation$13,385K Tsa payables andaccrued liabilities$253,908K Accrued rebates, feesand reserves$67,010K Accounts payable$24,893K

Coherus Oncology, Inc. (CHRS)

Coherus Oncology, Inc. (CHRS)